• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO BCT TRIMA ACCEL; TRIMA ACCEL LRS PLATELET, PLASMA, AUTO RBC SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO BCT TRIMA ACCEL; TRIMA ACCEL LRS PLATELET, PLASMA, AUTO RBC SET Back to Search Results
Catalog Number 80350
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code No Patient Involvement (2645)
Date of Event 09/10/2019
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Investigation: the run data file (rdf) was analyzed for this event.After reviewing the signals in the run data file, it cannot be ruled out that the repeated access alerts that occurred during the procedure disrupted the steady-state of the system and contributed to the elevated wbc content measured in the platelet product.Based on the available information, it also cannot be ruled out that the higher-than-expected wbc content in the platelet product could be donor-related.Investigation is in process.A follow up report will be provided.
 
Event or Problem Description
The customer would like the run data file investigated to determine a possible cause for the elevated white blood cell (wbc) content in the platelet product.There was not a transfusion recipient or patient involved at the time of the residual white bloodcell (rwbc) testing, therefore no patient information is reasonably known at the time of the event.Donor unit #: (b)(6).The platelet collection set is not available for return because it was discarded by the customer.
 
Additional Manufacturer Narrative
Investigation: the device history records (dhr) were reviewed for this lot.There were no events noted in the dhr that would have contributed to the elevated wbc count experienced by the customer.Root cause: a definitive root cause for the observed leukoreduction failure remains undetermined at this time.After reviewing the signals in the run data file, it cannot be ruled out that the repeated access alerts that occurred during the procedure disrupted the steady-state of the system and contributed to the elevated wbc content measured in the platelet product.Based on the available information, it also cannot be ruled out that the higher-than-expected wbc content in the platelet product could be donor-related.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TRIMA ACCEL
Common Device Name
TRIMA ACCEL LRS PLATELET, PLASMA, AUTO RBC SET
Manufacturer (Section D)
TERUMO BCT
lakewood CO 80215
MDR Report Key9156597
Report Number1722028-2019-00290
Device Sequence Number2606135
Product Code GKT
UDI-Device Identifier05020583803503
UDI-Public05020583803503
Combination Product (Y/N)N
Initial Reporter StateNY
Initial Reporter CountryUS
PMA/510(K) Number
BK190332
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source health professional
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 10/04/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date05/01/2021
Device Catalogue Number80350
Device Lot Number1905222130
Was Device Available for Evaluation? No
Was the Report Sent to FDA? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 09/11/2019
Supplement Date Received by Manufacturer11/14/2019
Initial Report FDA Received Date10/04/2019
Supplement Report FDA Received Date11/18/2019
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
-
-